Share

August 2016; 2 (4) EditorialOpen Access

A new dawn for genetic association studies in multiple sclerosis

Orhun H. Kantarci
First published August 4, 2016, DOI: https://doi.org/10.1212/NXG.0000000000000093
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
559

Share

Article Information

vol. 2 no. 4 e93
DOI: 
https://doi.org/10.1212/NXG.0000000000000093
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2376-7839
History: 
  • First Published August 4, 2016.
Copyright & Usage: 
© 2016 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Orhun H. Kantarci, MD
  1. Orhun H. Kantarci, MD
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. 1) Istanbul MS Days, Novartis Pharmaceuticals, speaker honoraria payment to Mayo Clinic. No personal compensation. 2) Invited professor program, Biogen- Boston, speaker honoraria payment to Mayo Clinic. No personal compensation

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Grant review for The National Multiple Sclerosis Society.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Already listed in the paper but reported again: Dr. Orhun Kantarci receives research support from the European Regional Development Fund (FNUSAICRC CZ.1.05/1.1.00/02.0123), the National Multiple Sclerosis Society, and has given a scientific presentation at a meeting supported by Teva Pharmaceuticals but has received no personal fees or personal compensation for this activity (all compensation for consulting activities paid directly to Mayo Clinic) nor has spoken about the specific medications involving this company. Dr.Kejal Kantarci serves on the data safety monitoring board of Takeda Global Research and Development Center, Inc, and the data monitoring boards of Pfizer Inc and Janssen Alzheimer Immunotherapy and is funded by the NIH (R01 AG040042 [PI], R21 NS066147 [PI], P50 AG44170/Project 2 [PI], P50 AG16574/Project 1 [PI], R01 AG11378[Co-I], U19 AG10483[Co-I] U01 AG042791[Co-I]) and Minnesota Partnership for Biotechnology and Medical Genomics (PO03590201[PI])

    Research Support, Government Entities:

    1. Dr.Kejal Kantarci (wife) serves on the data safety monitoring board of Takeda Global Research and Development Center, Inc, and the data monitoring boards of Pfizer Inc and Janssen Alzheimer Immunotherapy and is funded by the NIH (R01 AG040042 [PI], R21 NS066147 [PI], P50 AG44170/Project 2 [PI], P50 AG16574/Project 1 [PI], R01 AG11378[Co-I], U19 AG10483[Co-I] U01 AG042791[Co-I]) and Minnesota Partnership for Biotechnology and Medical Genomics (PO03590201[PI])

    Research Support, Academic Entities:

    1. Dr.Kejal Kantarci (wife) serves on the data safety monitoring board of Takeda Global Research and Development Center, Inc, and the data monitoring boards of Pfizer Inc and Janssen Alzheimer Immunotherapy and is funded by the NIH (R01 AG040042 [PI], R21 NS066147 [PI], P50 AG44170/Project 2 [PI], P50 AG16574/Project 1 [PI], R01 AG11378[Co-I], U19 AG10483[Co-I] U01 AG042791[Co-I]) and Minnesota Partnership for Biotechnology and Medical Genomics (PO03590201[PI])

    Research Support, Foundations and Societies:

    1. 2006-2009 Multiple Sclerosis Society for support in multiple sclerosis research unrelated to this publication; 2008-2009 Mayo Foundation CR20 award for support in multiple sclerosis research unrelated to this publication; 2009-2011 Hilton Foundation support in multiple sclerosis research unrelated to this publication

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology, Mayo Clinic, Rochester, MN.
  1. Correspondence to Dr. Kantarci: kantarci.orhun{at}mayo.edu
View Full Text

Article usage

Article usage: August 2016 to August 2023

AbstractFullPdfSource
Aug 20164235169Highwire
Sep 201690814Highwire
Oct 20164887Highwire
Nov 201640616Highwire
Dec 201631512Highwire
Jan 20173135Highwire
Feb 20171833Highwire
Mar 20172456Highwire
Apr 201724117Highwire
May 20171614Highwire
Jun 20171665Highwire
Jul 2017849Highwire
Aug 2017934Highwire
Sep 2017211Highwire
Oct 2017980Highwire
Nov 20171665Highwire
Dec 2017383Highwire
Jan 2018474Highwire
Feb 2018383Highwire
Mar 20181115Highwire
Apr 20181112Highwire
May 20181173Highwire
Jun 20180174Highwire
Jul 20180170Highwire
Aug 20183171Highwire
Sep 20183256Highwire
Oct 20183173Highwire
Nov 20182134Highwire
Dec 20181163Highwire
Jan 20190231Highwire
Feb 20195232Highwire
Mar 20192205Highwire
Apr 20194296Highwire
May 20190810Highwire
Jun 20191179Highwire
Jul 20190155Highwire
Aug 2019258Highwire
Sep 2019122Highwire
Oct 20190101Highwire
Nov 20191158Highwire
Dec 20192146Highwire
Jan 20200118Highwire
Feb 20200115Highwire
Mar 20203137Highwire
Apr 202051010Highwire
May 202051410Highwire
Jun 20201105Highwire
Jul 20202119Highwire
Aug 20201144Highwire
Sep 20201199Highwire
Oct 20201156Highwire
Nov 2020289Highwire
Dec 20202125Highwire
Jan 2021074Highwire
Feb 20211116Highwire
Mar 2021261Highwire
Apr 202132410Highwire
May 20212161Highwire
Jun 2021132Highwire
Jul 20212512Highwire
Aug 2021293Highwire
Sep 2021247Highwire
Oct 202152315Highwire
Nov 2021259Highwire
Dec 20215113Highwire
Jan 2022222Highwire
Feb 2022374Highwire
Mar 2022298Highwire
Apr 20220133Highwire
May 20225711Highwire
Jun 2022387Highwire
Jul 2022123Highwire
Aug 2022023Highwire
Sep 202231710Highwire
Oct 20221146Highwire
Nov 202255224Highwire
Dec 20221126Highwire
Jan 202342811Highwire
Feb 20231114Highwire
Mar 2023053Highwire
Apr 2023043Highwire
May 2023167Highwire
Jun 2023030Highwire
Jul 2023048Highwire
Aug 2023035Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles